Actions
Vienna
,
Austria
15 - 19 September 2025
European Association for the Study of Diabetes 61st Annual Meeting (EASD 2025)
Presentation schedule and materials
Monday, 15 September 2025
09:00
- 17:00
CEST
Symposium
Revolutionising Cardiometabolic Health: Innovating, Transforming and Progressing Care
Alice Cheng
;
Ania Jastreboff
;
Anna Secher
;
Antje Körner
;
Arya M. Sharma
;
Athena Philis-Tsimikas
;
Carel le Roux
;
Christoph Wanner
;
Harald Sourij
;
John Buse
;
Laurent Castera
;
Linong Ji
;
Matthias Blüher
;
Melanie Davies
;
Michele Senni
;
Mikael Rydén
;
Subodh Verma
;
W. Timothy Garvey
MATERIALS AVAILABLE
Tuesday, 16 September 2025
10:15
- 10:30
CEST
ORAL PRESENTATION
Oral semaglutide and cardiovascular outcomes by baseline A1c and BMI in people with type 2 diabetes in the SOUL trial
Silvio E. Inzucchi1; Rohana Abdul Ghani2; John Deanfield3; Mads D. M. Engelmann4; G. Kees Hovingh4; Ole K. Jeppesen4; Monika Kellerer5; Kabirdev Mandavya6; Johannes F. Mann7; Nikolaus Marx8; Chantal Mathieu9; Darren K. McGuire10; Viswanathan Mohan11; Sharon L. Mulvagh12; Rodica Pop-Busui13; Neil R. Poulter14; Maria Sejersten Ripa4; Gabriela Roman15; Róbinson Sánchez García16; Michael Shechter17; John B. Buse18; on behalf of the SOUL Study Group
MATERIALS AVAILABLE
Coming soon
12:00
- 13:00
CEST
873
SHORT ORAL PRESENTATION
Improved treatment satisfaction with once-weekly IcoSema vs daily basal-bolus therapy in adults with type 2 diabetes inadequately controlled on daily basal insulin (COMBINE 3)
Paolo Fiorina1; Malik Benamar2; Sin Gon Kim3; Raluca Maltesen4; Siri Vinther2; Liming Chen5
MATERIALS AVAILABLE
Coming soon
12:00
- 13:00
CEST
869
SHORT ORAL PRESENTATION
Efficacy and hypoglycaemia outcomes of once-weekly IcoSema in type 2 diabetes according to pre-trial sodium-glucose cotransporter-2 inhibitor use: a post hoc analysis of COMBINE 1–3
Linong Ji1; Jonas Dahl Andersen2; Sofie Bech Andersen3; Laura Pletsch-Borba3; Viswanathan Mohan4; Daisuke Yabe5
MATERIALS AVAILABLE
Coming soon
12:00
- 13:00
CEST
872
SHORT ORAL PRESENTATION
Gastrointestinal adverse events with once-weekly IcoSema: a post hoc analysis of COMBINE 1–3
André Vianna1; Jonas D Andersen2; Liming Chen3; Paolo Fiorina4; Thaís M P Rocha5; Siri Vinther5; Liana K Billings6
MATERIALS AVAILABLE
Coming soon
12:00
- 13:00
CEST
870
SHORT ORAL PRESENTATION
Continuous glucose monitoring-based outcomes in adults with type 2 diabetes receiving IcoSema vs comparators: post hoc analysis of COMBINE 1 and 3
Concetta Irace1; Vanja Cejvanovic2; Jonas H Larsen3; Thaís MP Rocha2; Yasuo Terauchi4; Chantal Mathieu5
MATERIALS AVAILABLE
Coming soon
12:00
- 13:00
CEST
871
SHORT ORAL PRESENTATION
Continuous glucose monitoring-derived model-based postprandial glucose with IcoSema vs other insulin regimens: a post hoc analysis of COMBINE 1 and 3
Christophe De Block1; Malik Benamar2; Ariel Fu2; Raluca Maltesen3; Francesco Giorgino4
MATERIALS AVAILABLE
Coming soon
16:15
- 16:45
CEST
Symposium
Proactive care: early detection and interdisciplinary approaches for managing chronic kidney disease and peripheral artery disease in people with T2D
Ildiko Lingvay
;
David Cherney
;
Marc P. Bonaca
MATERIALS AVAILABLE
18:00
- 19:30
CEST
Symposium
Person-centred care in obesity management: connecting with your patients
Carel le Roux
;
Paolo Sbraccia
;
Steven Kahn
;
Ildiko Lingvay
;
Domenica Rubino
MATERIALS AVAILABLE
Wednesday, 17 September 2025
13:00
- 14:00
CEST
895
SHORT ORAL PRESENTATION
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by diabetes duration: ONWARDS 1–5
Alice YY Cheng1; Gayathri Anil2; Luis Canani3; Jonas K Lindeløv4; Siri Vinther4; Chantal Mathieu5
MATERIALS AVAILABLE
Coming soon
14:30
- 14:45
CEST
ORAL PRESENTATION
Effects of oral semaglutide on hospitalisation rates in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: SOUL trial results
John B. Buse1; Nikolaus Marx2; Sharon L. Mulvagh3; John Deanfield4; Silvio E. Inzucchi5; Rodica Pop-Busui6; Johannes F. E. Mann7; Scott Emerson8; Neil R. Poulter9; Mads D.M. Engelmann10; G. Kees Hovingh10; Rohana Abdul Ghani11; Aslam Amod12; Stephen C. Bain13; Pardeep S. Jhund14; Aytekin Oguz15; Michael Shechter16; Alex Videmark10; Derrick Musinga17; Amin Ouahid Hessissen10; Marie Reeberg Sass10; Darren K. McGuire18; on behalf of the SOUL Study Group
MATERIALS AVAILABLE
Coming soon
17:45
- 19:15
CEST
Symposium
The evolving role of GLP-1RAs for holistic cardiovascular, kidney, liver and metabolic care
Steven Kahn
;
John Wilding
;
Paola Fioretto
;
Eric Lawitz
;
Subodh Verma
MATERIALS AVAILABLE
Thursday, 18 September 2025
10:45
- 14:15
CEST
147
ORAL PRESENTATION
Effect of semaglutide on body composition and proximal muscle strength: The STEP UP trial
Joran Hjelmesaeth1; Suhas Bhat2; Tim Garvey3;Kristoffer Jensen Kolnes4; Ildiko Lingvay5; Niklas Kahr Rasmussen4; Julio Rosenstock 6; Sean Wharton7
MATERIALS AVAILABLE
Coming soon
10:45
- 12:15
CEST
LBA 22
ORAL PRESENTATION
Incidence of non-arteritic ischaemic optic neuropathy (NAION) across completed phase 2, 3 and 4 trials evaluating the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide
Tina Vilsbøll1,2; Dikshit A3; Lloyd Paul Aiello4; Cecilia Rönnbäck5; Michael Stellfeld5; Michael Larsen6;
MATERIALS AVAILABLE
Coming soon
12:15
- 12:45
CEST
Symposium
A new era of cardiometabolic care: advancing holistic treatment ambitions with amylin
Alice Cheng
;
Arya M. Sharma
MATERIALS AVAILABLE
15:30
- 17:00
CEST
181
ORAL PRESENTATION
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by baseline HbA1c: ONWARDS 1–5
Alice YY Cheng1; Gayathri Anil2; Luis Canani3; Jonas K Lindeløv4; Siri Vinther4; Chantal Mathieu5
MATERIALS AVAILABLE
Coming soon
17:00
- 17:30
CEST
Symposium
From at-risk to recognition: improving detection of MASH
Lise Lotte Gluud
;
Harpreet Bajaj
MATERIALS AVAILABLE
Coming soon
Actions
Keywords